This article series tied to the HealthcareGo conference held in Charlotte, North Carolina, on Sept. 16-17, 2025, spotlights key takeaways from across the sector including, AI, healthcare finance, compliance and diligence strategies, and investment considerations. This installment focuses on current investment considerations in life sciences, offering a look into what industry leaders are experiencing and watching closely. This panel featured investors, lenders and regulatory experts, exploring trends, risks and opportunities in life sciences investing. Themes across the panel included current regulatory uncertainty, sector transformation due to AI and increasing competition from China, and optimism about the resilience of the innovation-driven sector.
Read the full article: Insights from the McGuireWoods Healthcare Growth & Operations Conference: Part 3 – Investment Considerations in Life Sciences //
Source: https://www.mcguirewoods.com/client-resources/alerts/2025/10/insights-from-the-mcguirewoods-healthcare-growth-operations-conference-part-3-investment-considerations-in-life-sciences/
